Search Results - "Nantel, Stephen H."

Thalidomide and rituximab in Waldenstrom macroglobulinemia by Treon, Steven P., Soumerai, Jacob D., Branagan, Andrew R., Hunter, Zachary R., Patterson, Christopher J., Ioakimidis, Leukothea, Briccetti, Frederick M., Pasmantier, Mark, Zimbler, Harvey, Cooper, Robert B., Moore, Maria, Hill, John, Rauch, Alan, Garbo, Lawrence, Chu, Luis, Chua, Cynthia, Nantel, Stephen H., Lovett, David R., Boedeker, Hans, Sonneborn, Henry, Howard, John, Musto, Paul, Ciccarelli, Bryan T., Hatjiharissi, Evdoxia, Anderson, Kenneth C.

“…Thalidomide enhances rituximab-mediated, antibody-dependent, cell-mediated cytotoxicity. We therefore conducted a phase 2 study using thalidomide and rituximab…”
Get full text

High-Dose Therapy and Autologous Hematopoietic Stem-Cell Transplantation Does Not Increase the Risk of Second Neoplasms for Patients With Hodgkin's Lymphoma: A Comparison of Conventional Therapy Alone Versus Conventional Therapy Followed by Autologous Hematopoietic Stem-Cell Transplantation by FORREST, Donna L, HOGGE, Donna E, SONG, Kevin W, VOSS, Nicholas J, GASCOYNE, Randy D, CONNORS, Joseph M, NEVILL, Thomas J, NANTEL, Stephen H, BARNETT, Michael J, SHEPHERD, John D, SUTHERLAND, Heather J, TOZE, Cynthia L, SMITH, Clayton A, LAVOLE, Julye C

“…To determine the incidence of second malignancies among patients with Hodgkin's lymphoma (HL) treated with autologous hematopoietic stem cell transplantation…”
Get full text

Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real‐world outcomes from a population‐based cohort by Stubbins, Ryan J., Stamenkovic, Maria, Roy, Claudie, Rodrigo, Judith, Chung, Shanee, Kuchenbauer, Florian C., Hay, Kevin A., White, Jennifer, Abou Mourad, Yasser, Power, Maryse M., Narayanan, Sujaatha, Forrest, Donna L., Toze, Cynthia L., Sutherland, Heather J., Nantel, Stephen H., Nevill, Thomas J., Karsan, Aly, Song, Kevin W., Sanford, David S.

“…Objectives Acute myeloid leukaemia (AML) is a disease of older adults, who are vulnerable to socio‐economic factors. We determined AML incidence in older…”
Get full text

Excellent real‐world outcomes of adults with Burkitt lymphoma treated with CODOX‐M/IVAC plus or minus rituximab by Zhu, Katie Y., Song, Kevin W., Connors, Joseph M., Leitch, Heather, Barnett, Michael J., Ramadan, Khaled, Slack, Graham W., Abou Mourad, Yasser, Forrest, Donna L., Hogge, Donna E., Nantel, Stephen H., Narayanan, Sujaatha, Nevill, Thomas J., Power, Maryse M., Sanford, David S., Sutherland, Heather J., Tucker, Tracy, Toze, Cynthia L., Sehn, Laurie H., Broady, Raewyn, Gerrie, Alina S.

“…Summary Treatment of Burkitt lymphoma (BL) with intensive, multi‐agent chemotherapy with aggressive central nervous system (CNS) prophylaxis results in high…”
Get full text

High-dose Benda-EAM versus BEAM in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplantation by Tsang, Erica S., Villa, Diego, Loscocco, Federica, Visani, Giuseppe, Power, Maryse, Guiducci, Barbara, Clissa, Cristina, Song, Kevin, Toze, Cynthia, Abou Mourad, Yasser, Sutherland, Heather, Sanford, David, Nantel, Stephen H., Sehn, Laurie H., Scott, David W., Savage, Kerry J., Connors, Joseph M., Gerrie, Alina S., Isidori, Alessandro

Get full text

Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care Center by Kodad, Shruthi Ganeshappa, Sutherland, Heather, Limvorapitak, Wasithep, Abou Mourad, Yasser, Barnett, Michael J., Forrest, Donna, Gerrie, Alina, Hogge, Donna E., Nantel, Stephen H., Narayanan, Sujaatha, Nevill, Thomas, Power, Maryse, Sanford, David, Toze, Cynthia, White, Jennifer, Broady, Raewyn, Song, Kevin

“…Autologous stem cell transplant (ASCT) is the preferred consolidation strategy to treat eligible patients with multiple myeloma (MM) and related plasma cell…”
Get full text

Multicolor Karyotyping and Clinicopathological Analysis of Three Intravascular Lymphoma Cases by Khoury, Haytham, Lestou, Valia S, Gascoyne, Randy D, Bruyere, Helene, Li, Charles H, Nantel, Stephen H, Dalal, Bakul I, Naiman, Shelly C, Horsman, Douglas E

“…Intravascular lymphoma (IVL) is a rare neoplastic disease characterized by the presence of large malignant lymphoid cells in small vessels. It is often…”
Get full text

Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk Population by Cherniawsky, Hannah M., AlAhwal, Hatem, Mourad, Yasser Abou, Forrest, Donna, Gerrie, Alina, Kuchenbauer, Florian, Nantel, Stephen H., Narayanan, Sujaatha, Nevill, Thomas, Power, Maryse, Sanford, David, Toze, Cynthia, White, Jennifer, Escano, Leo, Sutherland, Heather, Song, Kevin

“…Death within 1 year of autotransplant in patients with multiple myeloma is an uncommon but serious problem caused by early rapid relapse. It is associated with…”
Get full text

Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis by Limvorapitak, Wasithep, Barnett, Michael J., Hogge, Donna E., Forrest, Donna L., Nevill, Thomas J., Narayanan, Sujaatha, Power, Maryse M., Nantel, Stephen H., Broady, Raewyn, Song, Kevin W., Toze, Cynthia L., Mourad, Yasser Abou, Sutherland, Heather J., Gerrie, Alina S., White, Jennifer, Sanford, David S.

“…We compared outcomes for patients with acute myeloid leukemia with intermediate-risk karyotype receiving consolidation with autologous stem cell…”
Get full text

Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation by Sun, Haowei, Savage, Kerry J, Karsan, Aly, Slack, Graham W, Gascoyne, Randy D, Toze, Cynthia L, Sehn, Laurie H, Abou Mourad, Yasser, Barnett, Michael J, Broady, Raewyn C, Connors, Joseph M, Forrest, Donna L, Gerrie, Alina S, Hogge, Donna E, Narayanan, Sujaatha, Nevill, Thomas J, Nantel, Stephen H, Power, Maryse M, Sutherland, Heather J, Villa, Diego, Shepherd, John D, Song, Kevin W

“…Micro-Abstract Use of CODOX-M/IVAC+R (cyclophosphamide, vincristine, doxorubicin, methotrexate, cytarabine, ifosfamide, and etoposide, combined with rituximab)…”
Get full text

Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort by Toze, Cynthia L., Dalal, Chinmay B., Nevill, Thomas J., Gillan, Tanya L., Abou Mourad, Yasser R., Barnett, Michael J., Broady, Raewyn C., Forrest, Donna L., Hogge, Donna E., Nantel, Stephen H., Power, Maryse M., Song, Kevin W., Sutherland, Heather J., Smith, Clayton A., Narayanan, Sujaatha, Young, Sean S., Connors, Joseph M., Shepherd, John D.

“…Summary The curative potential of allogeneic haematopoietic stem cell transplant (allo HSCT) in chronic lymphocytic leukaemia CLL is established, with a…”
Get full text

Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels by Forrest, Donna L, Trainor, Shannon, Brinkman, Ryan R, Barnett, Michael J, Hogge, Donna E, Nevill, Thomas J, Shepherd, John D, Nantel, Stephen H, Toze, Cynthia L, Sutherland, Heather J, Song, Kevin W, Lavoie, Julye C, Power, Maryse M, Abou-Mourad, Yasser, Smith, Clayton A

“…Abstract Cytogenetic and molecular responses to standard-dose imatinib (IM) were correlated with trough IM plasma levels for 78 patients with chronic myeloid…”
Get full text

High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver by Lavoie, Julye C., Connors, Joseph M., Phillips, Gordon L., Reece, Donna E., Barnett, Michael J., Forrest, Donna L., Gascoyne, Randy D., Hogge, Donna E., Nantel, Stephen H., Shepherd, John D., Smith, Clayton A., Song, Kevin W., Sutherland, Heather J., Toze, Cynthia L., Voss, Nicholas J.S., Nevill, Thomas J.

“…Beginning in 1985, patients in British Columbia with Hodgkin lymphoma (HL) that was not controlled by conventional chemotherapy routinely underwent high-dose…”
Get full text

Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy by Tantiworawit, Adisak, Power, Maryse M., Barnett, Michael J., Hogge, Donna E., Nantel, Stephen H., Nevill, Thomas J., Shepherd, John D., Song, Kevin W., Sutherland, Heather J., Toze, Cynthia L., Abou-Mourad, Yasser R., Narayanan, Sujaatha, Broady, Raewyn C., Forrest, Donna L.

“…Abstract Sudden blast phase (SBP) is a rare event that occurs in an unpredictable fashion amongst patients with chronic myeloid leukemia (CML) who otherwise…”
Get full text

Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months) by Venner, Christopher P., Connors, Joseph M., Sutherland, Heather J., Shepherd, John D., Hamata, Linda, Mourad, Yasser Abou, Barnett, Michael J., Broady, Raewyn, Forrest, Donna L., Hogge, Donna E., Nantel, Stephen H., Narayanan, Sujaatha, Nevill, Thomas J., Nitta, Janet, Power, Maryse M., Toze, Cynthia L., Smith, Clayton A., Song, Kevin W.

“…The treatment of multiple myeloma (MM) has changed with the advent of thalidomide, bortezomib, and lenalidomide, the so-called novel agents (NAs). Given the…”
Get full text

Allogeneic haematopoietic stem‐cell transplantation for relapsed and refractory aggressive histology non‐Hodgkin lymphoma by Doocey, Richard T., Toze, Cynthia L., Connors, Joseph M., Nevill, Thomas J., Gascoyne, Randy D., Barnett, Michael J., Forrest, Donna L., Hogge, Donna E., Lavoie, Julye C., Nantel, Stephen H., Shepherd, John D., Sutherland, Heather J., Voss, Nicholas J., Smith, Clayton A., Song, Kevin W.

“…Summary Forty‐four patients with relapsed or refractory aggressive histology non‐Hodgkin lymphoma (NHL) (diffuse large B cell, n = 23; peripheral T cell, n =…”
Get full text

Normal Karyotype CALLA-Positive Adult Pre-B ALL: Dismal Outcome With Chemotherapy for Patients With Loss/Gain of ABL1 and/or BCR FISH Signals by Abou Mourad, Yasser R, Bhargava, Rahul, Bruyère, Hélène, Gillian, Tanya, Barnett, Michael J, Forrest, Donna L, Nevill, Thomas J, Toze, Cynthia L, Nantel, Stephen H, Shepherd, John D

“…Micro-Abstract Karyotype is a key prognostic marker in adult acute lymphoblastic leukemia (ALL) and a Philadelphia chromosome, a breakpoint cluster…”
Get full text

Long‐term disease‐free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation by Toze, Cynthia L., Barnett, Michael J., Connors, Joseph M., Gascoyne, Randy D., Voss, Nicholas J., Nantel, Stephen H., Nevill, Thomas J., Shepherd, John D., Sutherland, Heather J., Lavoie, Julye C., Forrest, Donna L., Song, Kevin W., Hogge, Donna E.

“…Summary Myeloablative allogeneic bone marrow transplantation (BMT) may be curative in patients with follicular non‐Hodgkin's lymphoma, however, the impact of…”
Get full text

Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma by Song, Kevin W., Barnett, Michael J., Gascoyne, Randy D., Horsman, Douglas E., Forrest, Donna L., Hogge, Donna E., Lavoie, Julyle C., Nantel, Stephen H., Nevill, Thomas J., Shepherd, John D., Smith, Clayton A., Sutherland, Heather J., Voss, Nicholas J., Toze, Cynthia L., Connors, Joseph M.

“…Summary High dose chemoradiotherapy and haematopoietic stem cell transplantation (SCT) is used as primary therapy for patients diagnosed with Burkitt lymphoma…”
Get full text

Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors by Nair, Anish P, Barnett, Michael J, Broady, Raewyn C, Hogge, Donna E, Song, Kevin W, Toze, Cynthia L, Nantel, Stephen H, Power, Maryse M, Sutherland, Heather J, Nevill, Thomas J, Abou Mourad, Yasser, Narayanan, Sujaatha, Gerrie, Alina S, Forrest, Donna L

“…Abstract Allogeneic hematopoietic stem cell transplantation (HSCT) remains the only known curative therapy for chronic myeloid leukemia (CML); however, it is…”
Get full text